A. Gordin

Effect of peripheral catechol‐O‐methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

John G. Nutt, William R. Woodward, R. M. Beckner et al. · Neurology · 1994 · 247 citations

Medicine, Neurology, Pharmacology +12

Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)

Werner Poewe, Günther Deuschl, A. Gordin et al. · Acta Neurologica Scandinavica · 2002 · 209 citations

Medicine, Pharmacology, Pharmacotherapy +16

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone

T. Ker�nen, A. Gordin, MariAnne Karlsson et al. · European Journal of Clinical Pharmacology · 1994 · 126 citations

Medicine, Pharmacokinetics, Pharmacology +8

Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients

Seppo Kaakkola, H. Teräväinen, S. Ahtila et al. · Neurology · 1994 · 115 citations

Medicine, Pharmacology, Pharmacotherapy +17

The Effect of Catechol-O-Methyl Transferase Inhibition by Entacapone on the Pharmacokinetics and Metabolism of Levodopa in Healthy Volunteers

Tapani Keränen, A. Gordin, V‐P. Harjola et al. · Clinical Neuropharmacology · 1993 · 110 citations

Medicine, Pharmacokinetics, Pharmacology +14